Jade Biosciences, Inc. (JBIO)
NASDAQ: JBIO · Real-Time Price · USD
7.22
+0.33 (4.79%)
At close: Jun 6, 2025, 4:00 PM
7.54
+0.32 (4.43%)
After-hours: Jun 6, 2025, 5:41 PM EDT

Jade Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024
Period Ending
Dec '24
Cash & Equivalents
69.39
Cash & Short-Term Investments
69.39
Prepaid Expenses
0.27
Total Current Assets
69.65
Other Long-Term Assets
3.15
Total Assets
72.8
Accounts Payable
1.29
Accrued Expenses
9.63
Other Current Liabilities
1.08
Total Current Liabilities
12
Long-Term Debt
107.6
Total Liabilities
119.6
Common Stock
0
Additional Paid-In Capital
0.18
Retained Earnings
-46.98
Total Common Equity
-46.8
Shareholders' Equity
-46.8
Total Liabilities & Equity
72.8
Total Debt
107.6
Net Cash (Debt)
-38.21
Net Cash Per Share
-7.64
Filing Date Shares Outstanding
5.82
Total Common Shares Outstanding
5.82
Working Capital
57.66
Book Value Per Share
-8.04
Tangible Book Value
-46.8
Tangible Book Value Per Share
-8.04
Source: S&P Global Market Intelligence. Standard template. Financial Sources.